According to the notice released by the National Health Commission on the evening of the 8th, "cervical deep lymphatic vessel/lymph node vein anastomosis" will not be used for the treatment of Alzheimer's disease in the future. According to the notice, the National Health Commission organized experts to evaluate the technology in accordance with the relevant provisions of the "Management Measures for Clinical Application of Medical Technology". The evaluation found that the technology is in the early exploration stage of clinical research, with unclear indications and contraindications, and lacks high-quality evidence-based medical evidence to support its safety and effectiveness. Cervical deep lymphatic vessel/node vein anastomosis "is a surgical procedure that anastomoses deep lymphatic vessels or nodes in the neck with adjacent veins. In recent years, some medical institutions have used it to treat Alzheimer's disease, which has sparked controversy. The notice requires local health administrative departments at all levels to urge medical institutions within their jurisdiction to stop using "cervical deep lymphatic vessel/lymph node vein anastomosis" for the treatment of Alzheimer's disease, and to provide follow-up services for relevant patients. At the same time, after the technology has sufficient relevant preclinical research evidence, guide qualified medical institutions to strengthen clinical research design, and conduct clinical research scientifically and standardly under the premise of sufficient ethical committee argumentation. The National Health Commission will organize further clinical demonstrations of the application of this technology in a timely manner based on clinical research results. After the notification is issued, institutions and personnel who still use this technology to treat Alzheimer's disease will be seriously dealt with by the health administrative department in accordance with relevant regulations. (New Society)